Skip to main content
. 2018 Feb 28;9(21):15721–15731. doi: 10.18632/oncotarget.24595

Table 2. Univariate and multivariate analyses of possible prognostic parameters for OS of GBM patients in the TCGA and REMBRANDT cohort.

Characteristic Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
TCGA cohort (n = 525)
 ANGPT2 1.344 (1.103–1.637) 0.003 1.015 (0.745–1.384) 0.924
 VEGFA 1.260 (1.036–1.532) 0.021 0.952 (0.712–1.273) 0.740
 ANGPT2*VEGFA 1.524 (1.238–1.875) <0.001 1.562 (1.021–2.388) 0.040
REMBRANDT cohort (n = 151)
 ANGPT2 1.212 (0.869–1.690) 0.256
 VEGFA 1.261 (0.905–1.758) 0.171
 ANGPT2*VEGFA 1.518 (1.055–2.185) 0.024